Pioneering 3D Human Tissues for Drug Discovery
Jan 06 | 2025
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Read More »Nov 20 | 2024
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting
Read More »Nov 13 | 2024
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases
Read More »